Leverage Cognate’s Unparalleled Cell-Based cGMP manufacturing expertise combined with a broad spectrum of targeted services for effective and optimized commercialization.
International experience providing full support through out all stages of commercial development. Cognate provides the most efficient translation from concept to market.
Cell Therapy Services
Access an array of technical and specialized manufacturing and development services backed by an unsurpassed track record and proven expertise with cell-based technologies.
Outstanding real-world experience in navigating the evolving international regulatory pathways coupled with global know-how in translating cGMP manufacturing between countries.
Notable Industry News
- Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America over SB623, Therapy for Stroke Read more →
- Peer-reviewed scientific publication highlighting CombiCult® technology demonstrates power of massively parallel stem cell differentiation Read more →
- Esperite ‘s R&D Division “The Cell Factory” implements GMP Stem Cell Bioproduction Technology and aims the Cerebral Palsy as first clinical trial. Read more: http://www.nasdaq.com/press-release/esperite-s-rd-division-the-cell-factory-implements-gmp-stem-cell-bioproduction-technology-and-aims-20140925-00023#ixzz3EiDhtbnR Read more →